These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28363207)

  • 21. Clinical practice guidelines on perioperative cardiovascular evaluation: collaborative efforts among the ACC, AHA, and ESC.
    Anderson JL; Antman EM; Harold JG; Jessup M; O'Gara PT; Pinto FJ; Vardas PE; Zamorano JL
    Circulation; 2014 Dec; 130(24):2213-4. PubMed ID: 25085963
    [No Abstract]   [Full Text] [Related]  

  • 22. [2014 ESC/EACTS Guidelines on myocardial revascularization].
    Windecker S; Kolh P; Alfonso F; Collet JP; Cremer J; Falk V; Filippatos G; Hamm C; Head SJ; Jüni P; Kappetein AP; Kastrati A; Knuuti J; Landmesser U; Laufer G; Neumann FJ; Richter DJ; Schauerte P; Uva MS; Stefanini GG; Taggart DP; Torracca L; Valgimigli M; Wijns W; Witkowski A; ; ;
    Kardiol Pol; 2014; 72(12):1253-379. PubMed ID: 25524605
    [No Abstract]   [Full Text] [Related]  

  • 23. [New european guidelines for dyslipidemia].
    Riesen WF; Virgini V; Vogt B; Rodondi N
    Rev Med Suisse; 2012 Mar; 8(331):525-6, 528-30. PubMed ID: 22471115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment andmanagement].
    Kristensen SD; Knuuti J; Saraste A; Anker S; Bøtker HE; De Hert S; Ford I; Gonzalez-Juanatey JR; Gorenek B; Heyndrickx GR; Hoeft A; Huber K; Iung B; Kjeldsen KP; Longrois D; Lüscher TF; Pierard L; Pocock S; Price S; Roffi M; Sirnes PA; Sousa-Uva M; Voudris V; Funck-Brentano C
    Kardiol Pol; 2014; 72(11):857-918. PubMed ID: 25524159
    [No Abstract]   [Full Text] [Related]  

  • 25. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).
    Kristensen SD; Knuuti J; Saraste A; Anker S; Bøtker HE; De Hert S; Ford I; Gonzalez Juanatey JR; Gorenek B; Heyndrickx GR; Hoeft A; Huber K; Iung B; Kjeldsen KP; Longrois D; Luescher TF; Pierard L; Pocock S; Price S; Roffi M; Sirnes PA; Uva MS; Voudris V; Funck-Brentano C;
    Eur J Anaesthesiol; 2014 Oct; 31(10):517-73. PubMed ID: 25127426
    [No Abstract]   [Full Text] [Related]  

  • 26. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).
    ; Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen MR; Tokgozoglu L; Verschuren WM; Vlachopoulos C; Wood DA; Zamorano JL
    Atherosclerosis; 2016 Oct; 253():281-344. PubMed ID: 27594540
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention guidelines and EAS/ESC guidelines for the treatment of dyslipidaemias: A look to the future.
    Catapano AL; Ray KK; Tokgözoglu L
    Atherosclerosis; 2022 Jan; 340():51-52. PubMed ID: 34863532
    [No Abstract]   [Full Text] [Related]  

  • 28. [ESC/EAS Guidelines for the management of dyslipidaemias].
    Reiner Ž; Catapano AL; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegría E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs RH; Kjekshus JK; Perrone Filardi P; Riccardi G; Storey RF; David W;
    Rev Esp Cardiol; 2011 Dec; 64(12):1168.e1-1168.e60. PubMed ID: 22115524
    [No Abstract]   [Full Text] [Related]  

  • 29. New ESC/EASD lipid guidelines empahsises need to expand cholesterol screening and treating to target in clinical practice.
    Aalbers J
    Cardiovasc J Afr; 2012 Mar; 23(2):118-20. PubMed ID: 22447481
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.
    Cuspidi C; Meani S; Salerno M; Severgnini B; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
    Blood Press; 2004; 13(3):144-51. PubMed ID: 15223722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Update on current care guideline: dyslipidaemias].
    Duodecim; 2013; 129(11):1198-9. PubMed ID: 23819207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinical perspective on the 2019 ESC/EAS guidelines for the management of dyslipidaemias: PCSK-9 inhibitors for all?
    Dykun I; Mahabadi AA; Rassaf T
    Eur Heart J; 2020 Jun; 41(24):2331. PubMed ID: 32031601
    [No Abstract]   [Full Text] [Related]  

  • 33. [Opinion of the Czech Atherosclerosis Society's committee (CSAT) on the ESC/EAS guidelines related to the diagnostics and treatment of dyslipidemias issued in 2011].
    Soška V; Vaverková H; Vráblík M; Bláha V; Cífková R; Freiberger T; Kraml P; Piťha J; Rosolová H; Stulc T; Urbanová Z
    Vnitr Lek; 2013 Feb; 59(2):120-6. PubMed ID: 23461401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simple multiplier to calculate the impact of HDL cholesterol on cardiovascular risk estimation using SCORE.
    Descamps OS; Cooney MT; De Backer G; Graham I
    Atherosclerosis; 2012 Jun; 222(2):564-6. PubMed ID: 22560327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How effective are the ESC/EAS and 2013 ACC/AHA guidelines in treating dyslipidemia? Lessons from a lipid clinic.
    Barkas F; Milionis H; Kostapanos MS; Mikhailidis DP; Elisaf M; Liberopoulos E
    Curr Med Res Opin; 2015 Feb; 31(2):221-8. PubMed ID: 25418708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
    Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
    JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Spanish interdisciplinary committee for cardiovascular disease prevention and the spanish society of cardiology position statement on dyslipidemia management. Differences between the European and american guidelines].
    Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR;
    Semergen; 2015 Apr; 41(3):149-57. PubMed ID: 25450438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comments on the ESC/EAS guidelines for the management of dyslipidaemias 2011. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology].
    Anguita M; Alegría E; Barrios V; Casasnovas JA; Escobar C; León M; Luengo E; Llisterri JL; Alonso Á; Cequier Á; Comín J; Fernández-Ortiz A; Heras M; Pan M; Worner F
    Rev Esp Cardiol; 2011 Dec; 64(12):1090-5. PubMed ID: 22107831
    [No Abstract]   [Full Text] [Related]  

  • 39. The 2016 version of the European Guidelines on Cardiovascular Prevention.
    Perk J
    Eur Heart J Cardiovasc Pharmacother; 2017 Jan; 3(1):9-10. PubMed ID: 28062656
    [No Abstract]   [Full Text] [Related]  

  • 40. The ESC Committee for Practice Guidelines (CPG).
    Eur Heart J; 2013 Mar; 34(10):703-4. PubMed ID: 23470961
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.